darunavir has been researched along with Sensitivity and Specificity in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Almehizia, AA; Darwish, IA; Herqash, RN | 1 |
| Estan-Cerezo, G; García-Monsalve, A; Navarro-Ruiz, A; Rodríguez-Lucena, FJ; Soriano-Irigaray, L | 1 |
| Feng, T; Jing, J; Liu, X; Mi, L; Shen, X; Wang, L; Zhang, R; Zhang, S; Zhao, J; Zhou, N | 1 |
| Guru Prasad, K; Nageswara Rao, R | 1 |
| A, VBR; Aris, AB; Jaafar, J; Majid, ZA; Talib, J; Umar, K; Yusop, Z | 1 |
| Calvez, V; Hill, A; Marcelin, AG | 1 |
| Hoogmartens, J; Iványi, T; Lázár, I; Leonard, S; Rosier, J; Van Schepdael, A; Vanstockem, M; Vermeersch, H | 1 |
| Alderden-Los, CG; Beijnen, JH; Hillebrand, MJ; Huitema, AD; Rosing, H; ter Heine, R; van Gorp, EC | 1 |
| Baietto, L; Bonora, S; D'Avolio, A; Di Perri, G; Lorena, B; Sciandra, M; Siccardi, M; Trentini, L | 1 |
1 trial(s) available for darunavir and Sensitivity and Specificity
| Article | Year |
|---|---|
Identification of new genotypic cut-off levels to predict the efficacy of lopinavir/ritonavir and darunavir/ritonavir in the TITAN trial.
Topics: Adult; Algorithms; Anti-HIV Agents; CD4 Lymphocyte Count; Darunavir; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Intention to Treat Analysis; Logistic Models; Lopinavir; Male; Mutation; Pyrimidinones; Ritonavir; RNA, Viral; Sensitivity and Specificity; Sulfonamides; Treatment Outcome; Viral Load | 2009 |
8 other study(ies) available for darunavir and Sensitivity and Specificity
| Article | Year |
|---|---|
Development of a highly sensitive ELISA for determination of darunavir in plasma samples using a polyclonal antibody with high affinity and specificity.
Topics: Antibodies; Antibody Affinity; Darunavir; Enzyme-Linked Immunosorbent Assay; Humans; Plasma; Sensitivity and Specificity | 2020 |
A rapid validated UV-HPLC method for the simultaneous determination of the antiretroviral compounds darunavir and raltegravir in their dosage form.
Topics: Anti-HIV Agents; Calibration; Chromatography, High Pressure Liquid; Darunavir; Dosage Forms; Drug Combinations; Limit of Detection; Raltegravir Potassium; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2017 |
Drug-Drug Interactions Between PA-824 and Darunavir Based on Pharmacokinetics in Rats by LC-MS-MS.
Topics: Animals; Chromatography, Liquid; Darunavir; Drug Interactions; Linear Models; Nitroimidazoles; Rats; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2018 |
LC-Q-TOF-MS/MS determination of darunavir and its metabolites in rat serum and urine: application to pharmacokinetics.
Topics: Animals; Chromatography, Liquid; Darunavir; Drug Stability; Rats; Rats, Wistar; Sensitivity and Specificity; Sulfonamides; Tandem Mass Spectrometry | 2014 |
Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
Topics: Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Darunavir; Drug Contamination; Drug Stability; Limit of Detection; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2016 |
Development of a capillary electrophoretic method for the separation of diastereoisomers of a new human immunodeficiency virus protease inhibitor.
Topics: Acetonitriles; Crown Ethers; Darunavir; Electrophoresis, Capillary; Emulsions; HIV Protease Inhibitors; Sensitivity and Specificity; Stereoisomerism; Sulfonamides | 2005 |
Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse tr
Topics: Chromatography, High Pressure Liquid; Darunavir; Drug Monitoring; HIV Protease Inhibitors; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Sulfonamides | 2007 |
HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.
Topics: Anti-Retroviral Agents; Chromatography, High Pressure Liquid; Darunavir; Drug Stability; HIV Infections; Humans; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides | 2007 |